Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tg.AC genetically altered mouse: assay working group overview of available data.

Toxicologic pathology - 1 Jan 2001

Eastin W C, Mennear J H, Tennant R W, Stoll R E, Branstetter D G, Bucher J R, McCullough B, Binder R L, Spalding J W, Mahler J F

Abstract excerpt

In a Government/Industry/Academic partnership to evaluate alternative approaches to carcinogenicity testing, 21 pharmaceutical agents representing a variety of chemical and pharmacological classes and possessing known human and or rodent carcinogenic potential were selected for study in several rodent models. The studies from this partnership project, coordinated by the International Life Sciences Institute,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinogenicity Tests
Share to Carcinogens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Mice, Transgenic

Share to Papilloma

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Share to Skin Neoplasms

Source

Identifiers

PMID: 11695563
DOI: 10.1080/019262301753178483

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tg.AC genetically altered mouse: assay working group overview of available data.PMID 11695563Read ↗

Evaluation of the Tg.AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals--practical pointers, mechanistic clues, and new questions.Semantic proximity Read ↗

An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype.Semantic proximity Read ↗

CB6F1-rasH2 Mouse: Overview of Available DataSemantic proximity Read ↗

The role of transgenic mouse models in carcinogen identification.Semantic proximity Read ↗

Use of genetically modified mouse models for evaluation of carcinogenic risk: considerations for the laboratory animal scientist.Semantic proximity Read ↗

Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models.Semantic proximity Read ↗

An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness.Semantic proximity Read ↗

The genetic toxicology of Gene-Tox non-carcinogens.Semantic proximity Read ↗

The Tg rasH2 Mouse in Cancer Hazard IdentificationSemantic proximity Read ↗

Use of Transgenic Mice in Carcinogenicity Hazard AssessmentSemantic proximity Read ↗

Establishing a laboratory animal model from a transgenic animal: RasH2 mice as a model for carcinogenicity studies in regulatory science.Semantic proximity Read ↗

Transgenic animal models in toxicology: historical perspectives and future outlook.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.